Winton Group’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-42,369
| Closed | -$1.64M | – | 602 |
|
|
2024
Q1 | $1.64M | Buy |
+42,369
| New | +$1.64M | 0.12% | 148 |
|
|
2023
Q2 | – | Sell |
-14,145
| Closed | -$339K | – | 831 |
|
|
2023
Q1 | $339K | Buy |
+14,145
| New | +$339K | 0.02% | 790 |
|
|
2022
Q3 | – | Sell |
-40,738
| Closed | -$722K | – | 968 |
|
|
2022
Q2 | $722K | Sell |
40,738
-15,001
| -27% | -$266K | 0.04% | 591 |
|
|
2022
Q1 | $1.14M | Buy |
55,739
+2,924
| +6% | +$59.5K | 0.06% | 422 |
|
|
2021
Q4 | $987K | Buy |
52,815
+15,226
| +41% | +$285K | 0.06% | 467 |
|
|
2021
Q3 | $742K | Sell |
37,589
-7,238
| -16% | -$143K | 0.04% | 660 |
|
|
2021
Q2 | $1.06M | Sell |
44,827
-1,875
| -4% | -$44.3K | 0.06% | 497 |
|
|
2021
Q1 | $1.11M | Sell |
46,702
-6,318
| -12% | -$150K | 0.06% | 402 |
|
|
2020
Q4 | $1.06M | Sell |
53,020
-84,029
| -61% | -$1.68M | 0.08% | 377 |
|
|
2020
Q3 | $2.85M | Sell |
137,049
-39,805
| -23% | -$829K | 0.09% | 354 |
|
|
2020
Q2 | $3.1M | Buy |
176,854
+54,473
| +45% | +$953K | 0.08% | 440 |
|
|
2020
Q1 | $2M | Sell |
122,381
-20,418
| -14% | -$333K | 0.05% | 577 |
|
|
2019
Q4 | $2.94M | Buy |
142,799
+114,280
| +401% | +$2.35M | 0.04% | 662 |
|
|
2019
Q3 | $327K | Buy |
+28,519
| New | +$327K | ﹤0.01% | 1244 |
|